Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1

Oncotarget

Volumn 7, Issue 41, 2016, Pages 66468-66479

  Diab, Mohammad ^a   Vitenshtein, Alon ^a   Drori, Yaron ^b,c   Yamin, Rachel ^a   Danziger, Oded ^c   Zamostiano, Rachel ^c   Mandelboim, Michal ^b,c   Bacharach, Eran ^c   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

CEACAM1; HMPV; Immune response; Immunity; Immunology and Microbiology Section; PAMPs; PRRs; RIG I; RLRs; SHP2

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; INTERFERON; INTERFERON RESPONSE FACTOR 3; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; VIRUS RNA; CD66 ANTIGENS; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ARTICLE; BINDING SITE; CEACAM1 GENE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; METAPNEUMOVIRUS INFECTION; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN SYNTHESIS; UPREGULATION; VIRUS GENE; VIRUS LOAD; ANIMAL; BIOSYNTHESIS; CHLOROCEBUS AETHIOPS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; METAPNEUMOVIRUS; PARAMYXOVIRUS INFECTION; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTION; VERO CELL LINE; VIROLOGY;

ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; CERCOPITHECUS AETHIOPS; HUMANS; IMMUNITY, INNATE; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; UP-REGULATION; VERO CELLS;

EID: 84993949741     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11979     Document Type: Article

References (43)

1. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA and Osterhaus AD. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nature medicine. 2001; 7:719-724.
2. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF and Crowe JE, Jr. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. The New England journal of medicine. 2004; 350:443-450.
3. Williams JV, Wang CK, Yang CF, Tollefson SJ, House FS, Heck JM, Chu M, Brown JB, Lintao LD, Quinto JD, Chu D, Spaete RR, Edwards KM, Wright PF and Crowe JE, Jr. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. The Journal of infectious diseases. 2006; 193:387-395.
4. van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R, Osterhaus AD and Fouchier RA. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. The Journal of infectious diseases. 2003; 188:1571-1577.
5. Peiris JS, Tang WH, Chan KH, Khong PL, Guan Y, Lau YL and Chiu SS. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerging infectious diseases. 2003; 9:628-633.
6. Mullins JA, Erdman DD, Weinberg GA, Edwards K, Hall CB, Walker FJ, Iwane M and Anderson LJ. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerging infectious diseases. 2004; 10:700-705.
7. Mackay IM, Bialasiewicz S, Jacob KC, McQueen E, Arden KE, Nissen MD and Sloots TP. Genetic diversity of human metapneumovirus over 4 consecutive years in Australia. The Journal of infectious diseases. 2006; 193:1630-1633.
8. Dollner H, Risnes K, Radtke A and Nordbo SA. Outbreak of human metapneumovirus infection in norwegian children. The Pediatric infectious disease journal. 2004; 23:436-440.
9. Williams JV, Martino R, Rabella N, Otegui M, Parody R, Heck JM and Crowe JE, Jr. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. The Journal of infectious diseases. 2005; 192:1061-1065.
10. Larcher C, Geltner C, Fischer H, Nachbaur D, Muller LC and Huemer HP. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. The Journal of heart and lung transplantation. 2005; 24:1891-1901.
11. Williams JV, Crowe JE, Jr., Enriquez R, Minton P, Peebles RS, Jr., Hamilton RG, Higgins S, Griffin M and Hartert TV. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. The Journal of infectious diseases. 2005; 192:1149-1153.
12. Madhi SA, Ludewick H, Abed Y, Klugman KP and Boivin G. Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clinical infectious diseases. 2003; 37:1705-1710.
13. Bastien N, Ward D, Van Caeseele P, Brandt K, Lee SH, McNabb G, Klisko B, Chan E and Li Y. Human metapneumovirus infection in the Canadian population. Journal of clinical microbiology. 2003; 41:4642-4646.
14. Hamelin ME, Cote S, Laforge J, Lampron N, Bourbeau J, Weiss K, Gilca R, DeSerres G and Boivin G. Human metapneumovirus infection in adults with communityacquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clinical infectious diseases. 2005; 41:498-502.
15. Garcia-Garcia ML, Calvo C, Casas I, Bracamonte T, Rellan A, Gozalo F, Tenorio T and Perez-Brena P. Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatric pulmonology. 2007; 42:458-464.
16. Kahn JS. Epidemiology of human metapneumovirus. Clinical microbiology reviews. 2006; 19:546-557.
17. Panda S, Mohakud NK, Pena L and Kumar S. Human metapneumovirus: review of an important respiratory pathogen. International journal of infectious diseases. 2014; 25:45-52.
18. Seth RB, Sun L and Chen ZJ. Antiviral innate immunity pathways. Cell research. 2006; 16:141-147.
19. Meylan E, Tschopp J and Karin M. Intracellular pattern recognition receptors in the host response. Nature. 2006; 442:39-44.
20. Kawai T and Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature immunology. 2010; 11:373-384.
21. Kumar H, Kawai T and Akira S. Toll-like receptors and innate immunity. Biochemical and biophysical research communications. 2009; 388:621-625.
22. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y and Bose S. Activation of innate immune antiviral responses by Nod2. Nature immunology. 2009; 10:1073-1080.
23. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG and Gale M, Jr. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. Journal of virology. 2008; 82:335-345.
24. Yoneyama M, Onomoto K, Jogi M, Akaboshi T and Fujita T. Viral RNA detection by RIG-I-like receptors. Current opinion in immunology. 2015; 32:48-53.
25. Bao X, Liu T, Spetch L, Kolli D, Garofalo RP and Casola A. Airway epithelial cell response to human metapneumovirus infection. Virology. 2007; 368:91-101.
26. Goutagny N, Jiang Z, Tian J, Parroche P, Schickli J, Monks BG, Ulbrandt N, Ji H, Kiener PA, Coyle AJ and Fitzgerald KA. Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. Journal of immunology. 2010; 184:1168-1179.
27. Spann KM, Loh Z, Lynch JP, Ullah A, Zhang V, Baturcam E, Werder RB, Khajornjiraphan N, Rudd P, Loo YM, Suhrbier A, Gale M, Jr., Upham JW and Phipps S. IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice. The American journal of pathology. 2014; 184:1795-1806.
28. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. The Journal of biological chemistry. 2007; 282:15325-15329.
29. Liao S, Bao X, Liu T, Lai S, Li K, Garofalo RP and Casola A. Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. The Journal of general virology. 2008; 89:1978-1986.
30. Obrink B. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Current opinion in cell biology. 1997; 9:616-626.
31. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F, Hammarstrom S, Holmes KV, Karlsson A, Kuroki M, Lin SH, Lucka L, Najjar SM, et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Experimental cell research. 1999; 252:243-249.
32. Gray-Owen SD and Blumberg RS. CEACAM1: contact-dependent control of immunity. Nature reviews Immunology. 2006; 6:433-446.
33. Watt SM, Teixeira AM, Zhou GQ, Doyonnas R, Zhang Y, Grunert F, Blumberg RS, Kuroki M, Skubitz KM and Bates PA. Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood. 2001; 98:1469-1479.
34. Stern N, Markel G, Arnon TI, Gruda R, Wong H, Gray-Owen SD and Mandelboim O. Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1. Journal of immunology. 2005; 174:6692-6701.
35. Nouvion AL, Oubaha M, Leblanc S, Davis EC, Jastrow H, Kammerer R, Breton V, Turbide C, Ergun S, Gratton JP and Beauchemin N. CEACAM1: a key regulator of vascular permeability. Journal of cell science. 2010; 123:4221-4230.
36. Muller MM, Klaile E, Vorontsova O, Singer BB and Obrink B. Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src. The Journal of cell biology. 2009; 187:569-581.
37. Herfst S, de Graaf M, Schickli JH, Tang RS, Kaur J, Yang CF, Spaete RR, Haller AA, van den Hoogen BG, Osterhaus AD and Fouchier RA. Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. Journal of virology. 2004; 78:8264-8270.
38. Halenius A, Hauka S, Dolken L, Stindt J, Reinhard H, Wiek C, Hanenberg H, Koszinowski UH, Momburg F and Hengel H. Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. Journal of virology. 2011; 85:3473-3485.
39. Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M, van den Hoogen BG, Spaete R, Osterhaus AD and Fouchier RA. Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. Journal of clinical microbiology. 2004; 42:981-986.
40. Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, Lieberman N, Gazit R, Joseph A, Kedar E and Mandelboim O. Enhanced recognition of human NK receptors after influenza virus infection. Journal of immunology. 2003; 171:915-923.
41. Sabo Y, Ehrlich M and Bacharach E. The conserved YAGL motif in human metapneumovirus is required for higherorder cellular assemblies of the matrix protein and for virion production. Journal of virology. 2011; 85:6594-6609.
42. Eisenacher K and Krug A. Regulation of RLR-mediated innate immune signaling-it is all about keeping the balance. European journal of cell biology. 2012; 91:36-47.
43. Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E, Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, et al. CEACAM1-Mediated Inhibition of Virus Production. Cell reports. 2016; 15:2331-2339.